A defensin from the model beetle Tribolium castaneum acts synergistically with telavancin and daptomycin against multidrug resistant Staphylococcus aureus

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Rajamuthiah, Rajmohan ^a,b   Jayamani, Elamparithi ^a,b   Conery, Annie L ^b   Fuchs, Beth Burgwyn ^a   Kim, Wooseong ^a   Johnston, Tatiana ^a   Vilcinskas, Andreas ^c   Ausubel, Frederick M ^b   Mylonakis, Eleftherios ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; DEFENSIN 1; OXACILLIN; PSEUDOMONIC ACID; TELAVANCIN; UNCLASSIFIED DRUG; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; DEFENSIN; INSECT PROTEIN;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG POTENTIATION; ERYTHROCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; SURVIVAL RATE; TRIBOLIUM CASTANEUM; ANIMAL; CELL CULTURE; CELL SURVIVAL; CELL WALL; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TRIBOLIUM;

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; COLEOPTERA; HEXAPODA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS; TRIBOLIUM CASTANEUM;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CAENORHABDITIS ELEGANS; CELL SURVIVAL; CELL WALL; CELLS, CULTURED; DAPTOMYCIN; DEFENSINS; DRUG SYNERGISM; ERYTHROCYTES; HUMANS; INSECT PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; TRIBOLIUM;

EID: 84936876425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128576     Document Type: Article

References (31)

1. Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence peptides and their clinical applications. Cellular and molecular life sciences: CMLS. 2011; 68(13):2161-76. doi: 10.1007/s00018-011-0710-x PMID: 21573784
2. Hilchie AL, Wuerth K, Hancock RE. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nature chemical biology. 2013; 9(12):761-8. doi: 10.1038/nchembio.1393 PMID: 24231617
3. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008; 46 Suppl 5: S344-9.
4. Altincicek B, Knorr E, Vilcinskas A. Beetle immunity: Identification of immune-inducible genes from the model insect Tribolium castaneum. Developmental and comparative immunology. 2008; 32(5):585-95. PMID: 17981328
5. Rajamuthiah R, Fuchs BB, Jayamani E, Kim Y, Larkins-Ford J, Conery A, et al. Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus. PloS one. 2014; 9(2):e89189. doi: 10.1371/journal.pone.0089189 PMID: 24586584
6. Beanan MJ, Strome S. Characterization of a germ-line proliferation mutation in C. elegans. Development. 1992; 116(3):755-66. PMID: 1289064
7. Tanaka-Hino M, Sagasti A, Hisamoto N, Kawasaki M, Nakano S, Ninomiya-Tsuji J, et al. SEK-1 MAPKK mediates Ca2+ signaling to determine neuronal asymmetric development in Caenorhabditis elegans. EMBO reports. 2002; 3(1):56-62. PMID: 11751572
8. Poppel AK, Vogel H, Wiesner J, Vilcinskas A. Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria. Antimicrobial agents and chemotherapy. 2015.
9. Vilcinskas A, Mukherjee K, Vogel H. Expansion of the antimicrobial peptide repertoire in the invasive ladybird Harmonia axyridis. Proceedings Biological sciences / The Royal Society. 2013; 280(1750):20122113. doi: 10.1098/rspb.2012.2113 PMID: 23173204
10. Vilcinskas A. Anti-infective therapeutics from the Lepidopteran model host Galleria mellonella. Current pharmaceutical design. 2011; 17(13):1240-5. PMID: 21470117
11. Draper LA, Cotter PD, Hill C, Ross RP. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. BMC microbiology. 2013; 13:212. doi: 10.1186/1471-2180-13-212 PMID: 24069959
12. Rosch JW, Boyd AR, Hinojosa E, Pestina T, Hu Y, Persons DA, et al. Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. The Journal of clinical investigation. 2010; 120(2):627-35. doi: 10.1172/JCI39843 PMID: 20093777
13. Chu HL, Yu HY, Yip BS, Chih YH, Liang CW, Cheng HT, et al. Boosting salt resistance of short antimicrobial peptides. Antimicrobial agents and chemotherapy. 2013; 57(8):4050-2. doi: 10.1128/AAC.00252-13 PMID: 23716061
14. Brown S, Santa Maria JP Jr., Walker S. Wall teichoic acids of gram-positive bacteria. Annual review of microbiology. 2013; 67:313-36. doi: 10.1146/annurev-micro-092412-155620 PMID: 24024634
15. Santa Maria JP Jr., Sadaka A, Moussa SH, Brown S, Zhang YJ, Rubin EJ, et al. Compound-gene interaction mapping reveals distinct roles for Staphylococcus aureus teichoic acids. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(34):12510-5. doi: 10.1073/pnas.1404099111 PMID: 25104751
16. Nuding S, Frasch T, Schaller M, Stange EF, Zabel LT. Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile. Antimicrobial agents and chemotherapy. 2014; 58(10):5719-25. doi: 10.1128/AAC.02542-14 PMID: 25022581
17. Singh PK, Sharma S, Kumari A, Korpole S. A non-pediocin low molecular weight antimicrobial peptide produced by Pediococcus pentosaceus strain IE-3 shows increased activity under reducing environment. BMC microbiology. 2014; 14:226. doi: 10.1186/s12866-014-0226-2 PMID: 25158757
18. Lunde CS, Hartouni SR, Janc JW, Mammen M, Humphrey PP, Benton BM. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrobial agents and chemotherapy. 2009; 53(8):3375-83. doi: 10.1128/AAC.01710-08 PMID: 19470513
19. Pogliano J, Pogliano N, Silverman JA. Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. Journal of bacteriology. 2012; 194(17):4494-504. doi: 10.1128/JB.00011-12 PMID: 22661688
20. Ntwasa M, Goto A, Kurata S. Coleopteran antimicrobial peptides: prospects for clinical applications. International journal of microbiology. 2012; 2012:101989. doi: 10.1155/2012/101989 PMID: 22500175
21. Lowenberger C. Innate immune response of Aedes aegypti. Insect biochemistry and molecular biology. 2001; 31(3):219-29. PMID: 11167091
22. Mizukawa N, Sugiyama K, Ueno T, Mishima K, Takagi S, Sugahara T. Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral diseases. 1999; 5(2):139-42. PMID: 10522210
23. Sifri CD, Begun J, Ausubel FM, Calderwood SB. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infection and immunity. 2003; 71(4):2208-17. PMID: 12654843
24. Rahnamaeian M, Cytrynska M, Zdybicka-Barabas A, Dobslaff K, Wiesner J, Twyman R, et al. Insect antimicrobial peptides show potentiating functional interactions against Gram-negative bacteria. Proceedings of the Royal Society B. 2015.
25. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrobial agents and chemotherapy. 2000; 44(8):2086-92. PMID: 10898680
26. Eckert R, Qi F, Yarbrough DK, He J, Anderson MH, Shi W. Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrobial agents and chemotherapy. 2006; 50(4):1480-8. PMID: 16569868
27. Mondhe M, Chessher A, Goh S, Good L, Stach JE. Species-selective killing of bacteria by antimicrobial peptide-PNAs. PloS one. 2014; 9(2):e89082. doi: 10.1371/journal.pone.0089082 PMID: 24558473
28. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of clinical microbiology. 2003; 41(11):5113-20. PMID: 14605147
29. Nair D, Memmi G, Hernandez D, Bard J, Beaume M, Gill S, et al. Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. Journal of bacteriology. 2011; 193(9):2332-5. doi: 10.1128/JB.00027-11 PMID: 21378186
30. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. Journal of bacteriology. 2008; 190(1):300-10. PMID: 17951380
31. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, Laufs R. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infection and immunity. 1994; 62(8):3244-53. PMID: 8039894